phase iii admet2 trial of methylphenidate for apathy in alzheimer's disease
Published 3 years ago • 323 plays • Length 7:14Download video MP4
Download video MP3
Similar videos
-
3:17
impact of alzheimer's disease treatments on apathy
-
9:17
phase ii trial of xpro1595 for the treatment of alzheimer’s disease
-
4:23
phase ii trial of ar1001 as a potential treatment for alzheimer’s disease
-
18:06
phase ii/iii gain trial results: atuzaginstat for disease modification in alzheimer’s disease
-
2:04
apathy in dementia
-
2:46
phase ii/iii gain trial of a novel lysine-gingipain inhibitor for the treatment of alzheimer’s
-
4:21
phase ii trial of acu193 in alzheimer’s disease
-
0:46
uncovering the reality of end-stage alzheimer's: how the dying process unfolds 😶🌫
-
6:34
phase iia exploratory trial of t3d-959 in mild-moderate alzheimer’s disease
-
2:35
inmune bio phase 2 clinical trial of xpro in alzheimer's disease
-
53:55
diagnosis and treatment of dementia-related apathy: recent advances
-
3:45
impact of apathy on memory and aging
-
0:28
5 surprising things that can happen in dementia
-
1:10
new alzheimer's disease clinical trial: avp-786 for alzheimer's disease
-
1:40
new diagnostic criteria for apathy in neurocognitive disorders
-
5:56
trial for alzheimer's shows cognitive improvement in subjects
-
1:34
new alzheimer disease clinical trial: semaglutide for alzheimer disease
-
1:12
new alzheimer's disease clinical trial: acu193 for alzheimer's disease
-
1:12
new alzheimer disease clinical trial: psilocybin for alzheimer disease